Figure 5 | Scientific Reports

Figure 5

From: BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression

Figure 5

Effects of BKM120 and olaparib on the PI3K/Akt/NFκB/c-Myc signaling pathway. Effects of BKM120, olaparib, and a combination of BKM120 and olaparib on the expressions of PI3K, Akt, NFκB and c-Myc in MDA-MB-231 cells analyzed by (A) RT-PCR and western blots (C). (E) Effects of drugs on the phosphorylation of PI3K, Akt, and NFκB analyzed by western blots. Relative intensity expression obtained from the corresponding (B) RT-PCR and (E,F) western blots. Error bars represent SEM from the mean of three separate experiments. *P < 0.05 and **P < 0.01 compared to control, #P < 0.05 and ##P < 0.01 compared to 3.2 μM BMK120-treated group.

Back to article page